drugset / Trial / NCT00534794

Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis

NCT00534794

Phase 4 Completed 79 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effects of two marked ocular anti-allergy medications in cat sensitive subjects with allergic conjunctivitis.

Timeline

Start
2007-10
Primary completion
2008-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinastine Small molecule
Comparator Olopatadine Other / unclassified

Indications